Ironwood Pharmaceuticals, Inc. - (IRWD) Social Stream
Ironwood Pharmaceuticals Inc (IRWD) Price Targets From Analysts
Use the tables below to see what analysts covering Ironwood Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $15 | $9 | $12.75 | $12.65 | 0.79% |
| 2022-01-10 | 3 | $15 | $9 | $12.333 | $12.65 | -2.51% |
| 2022-02-18 | 3 | $15 | $9 | $12 | $12.65 | -5.14% |
The Trend in the Analyst Price Target
IRWD's average price target has moved up $0.17 over the prior 21 months.
Over the past 45 weeks, IRWD's average upside potential has been 4.6%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 8 | 20 | 9 | 12.670 | 11.84 | 7.01% |
| 2021-07-03 | 8 | 20 | 9 | 12.670 | 12.58 | 0.72% |
| 2021-09-11 | 8 | 20 | 9 | 13.830 | 12.20 | 13.36% |
| 2021-11-08 | 3 | 15 | 9 | 12.750 | 13.20 | -3.41% |
| 2022-01-10 | 3 | 15 | 9 | 12.333 | 11.90 | 3.64% |
IRWD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 31 days, IRWD's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of Pharmaceutical Products stocks, Ironwood Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 7.42% of them.
- In the context of stocks in the mid market cap category, Ironwood Pharmaceuticals Inc's average analyst price target is greater than 28.32% of them.
- IRWD has a greater number of analysts covering the stock than 32.32% of stocks in the mid market cap category.
- Ironwood Pharmaceuticals Inc's variance in analysts' estimates is lower than -92.94% of stocks in the mid market cap category.
Stocks similar to Ironwood Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are INVA, INSM, and INFI.
What is the outlook for IRWD? Use POWR Ratings for clearer insight into price direction.